Tailor-made Antibodies
and Tools for Life Science
Home|||||Technical Support

Neurofilament L antibody - 171 003BT

Neurofilaments are major neuronal intermediate filaments
Rabbit polyclonal IgG fraction
Cat. No.: 171 003BT
Amount: 100 µg
Price: $485.00
Cat. No. 171 003BT 100 µg antibody, lyophilized. For reconstitution add 100 µl H2O, then aliquot and store at -20°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
WB: 1 : 500 up to 1 : 1000 (AP staining) (see remarks) gallery  
IP: not tested yet
ICC: 1 : 100 (see remarks) gallery  
IHC: 1 : 100
IHC-P: 1 : 100 up to 1 : 500 gallery  

Western blot (WB); separation of proteins by PAGE and subsequent transfer to a membrane. Detection of target molecules is carried out with antibodies. Some antibodies require special sample preparation steps. For details, please refer to the “Remarks” section.

Immunoprecipitation (IP); Immunoisolation or pulldown of a target molecule using an antibody. For details and product specific hints, please refer to the ”Remarks” section.

Immunocytochemistry (ICC) on 4% PFA fixed cells. Immunoreactivity is usually revealed by fluorescence. Some antibodies require special fixation methods. For details, please refer to the “Remarks” section.

Immunohistochemistry (IHC) on 4% PFA perfusion fixed tissue with 24h PFA post fixation. Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate. Some antibodies require special fixation methods or antigen retrieval steps. For details, please refer to the ”Remarks” section.

Immunohistochemistry (IHC-P) of formalin fixed, paraffin embedded (FFPE) tissue (some antibodies require special antigen retrieval steps, please refer to the ”Remarks” section). Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate.

Label biotin
Immunogen with AA 200-292 missing. Immunogen corresponds to AA 1 to 284 in AAH66952.1 (UniProt Id: P07196)
Reactivity Reacts with: human (P07196), rat (P19527), mouse (P08551).
Other species not tested yet.
Remarks

WB: This antibody is less sensitive than the crude rabbit antiserum (cat. no. 171 002)
ICC: Methanol fixation is recommended.

Data sheet 171_003bt.pdf

References for Neurofilament L - 171 003BT

Simultaneous alterations of oligodendrocyte-specific CNP, astrocyte-specific AQP4 and neuronal NF-L demarcate ischemic tissue after experimental stroke in mice.
Mages B, Aleithe S, Blietz A, Krueger M, Härtig W, Michalski D
Neuroscience letters (2019) : 134405. 171 003BT IHC; tested species: mouse
Cat. No.: 171 003BT
Amount: 100 µg
Price: $485.00
Simultaneous alterations of oligodendrocyte-specific CNP, astrocyte-specific AQP4 and neuronal NF-L demarcate ischemic tissue after experimental stroke in mice.
Mages B, Aleithe S, Blietz A, Krueger M, Härtig W, Michalski D
Neuroscience letters (2019) : 134405. 171 003BT IHC; tested species: mouse
Background

Neurofilaments (NFs) are intermediate filaments essential for providing structural support to neurons, particularly within axons. They play a crucial role in maintaining axonal diameter, which directly influences nerve conduction velocity (1). Neurofilaments are composed of three primary subunits - NF-L (light), NF-M (medium) and NF-H (heavy) – along with an NF-associated protein. In the adult central nervous system (CNS), α-internexin serves as the fourth neurofilament subunit, whereas in the peripheral nervous system (PNS), peripherin takes on this role (2).
Beyond their structural function, neurofilaments are also valuable biomarkers in both research and clinical settings. They are widely used in immunohistochemistry to stain and visualize axons, particularly in peripheral nerves and the CNS. Increased levels of neurofilament proteins in cerebrospinal fluid (CSF) or blood are strongly associated with neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Alzheimer’s disease (3). In peripheral nerve studies, neurofilament staining is often combined with other markers, such as S100, to provide a more comprehensive assessment of nerve structure and pathology (4).